Document is current
Any future updates will be listed below
-
Authors
Balcioglu, Hayri E.
Wijers, Rebecca
Smid, Marcel
Hammerl, Dora
Trapman-Jansen, Anita M.
Oostvogels, Astrid
Timmermans, Mieke
Martens, John W. M.
Debets, Reno
-
Funding
Funding for this research was provided by:
Erasmus MC Daniel den Hoed Foundation (Awarded to Reno Debets, 2017, Awarded to Reno Debets, 2017, Awarded to Reno Debets, 2017)
- License Information
-
More Information
Article History
Received: 21 September 2023
Accepted: 11 June 2024
First Online: 25 July 2024
Competing interests
: Dora Hammerl is a full-time employee and shareholder of Pan Cancer T BV. Reno Debets has received research support from MSD and Bayer, personal fees from Bluebird Bio, Genticel, other support from Pan Cancer T BV outside the submitted work (all paid to the Erasmus MC Cancer Institute), and is listed as an inventor for European patent application no’s. 21152822.9 and 21184727.2 (pending to Erasmus MC). Rest of the authors declare no competing interests.
